Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: Vitamin D May Not Be the Answer to SAD » Larry Hoover

Posted by jrbecker76 on March 18, 2009, at 15:16:04

In reply to Re: Vitamin D May Not Be the Answer to SAD » jrbecker76, posted by Larry Hoover on March 18, 2009, at 14:30:20

> I found the abstract, and here are the results:
> Results
> The prevalence of depressive symptoms was lower in the top tertile of 25(OH)D concentrations compared to the lowest tertile (7.2% vs. 11.1%) in the study population (odds ratio, 0.62; 95% confidence interval, 0.460.83; P for trend = 0.002). This association was substantially attenuated after controlling for various confounding factors, and disappeared after including geographic location in the model. Stratified analysis by location did not find any association between depressive symptoms and 25(OH)D levels among participants from either Beijing or Shanghai.
>
> I'd be really interested to know how it was that they got a highly significant result to disappear, i.e. what were the confounding factors, and how geographical location was presumed to modify the finding. If anyone has access to the full text (Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese) , I'd be interested in seeing it.
>
> Regards,
> Lar
>

here you go Lar. I can send you a pdf version if you wish....
-----------------------------

Brief report

Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese

An Pana, Ling Lua, Oscar H. Franconext termb, c, Zhijie Yua, Huaixing Lia and Xu Lina, Corresponding Author Contact Information, E-mail The Corresponding Author

aKey Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Graduate School of the Chinese Academy of Sciences, Shanghai, 200031, China

bUnilever R&D, Colworth Science Park, Sharnbrook, Bedfordshire, MK441LQ, United Kingdom

cHealth Sciences Research Institute, University of Warwick, Coventry, CV4 7AL, United Kingdom

Received 7 January 2009;
revised 3 February 2009;
accepted 3 February 2009.
Available online 27 February 2009.

Abstract
Background

Vitamin D deficiency is recently speculated to play a role in the development of depression. Nevertheless, few studies have explored the association between blood 25-hydroxyvitamin D [25(OH)D] concentrations and depression in the general population. Therefore, we aimed to determine this association in middle-aged and elderly Chinese.
Methods

We conducted a population-based cross-sectional study in 2005 in Beijing and Shanghai, China. Participants included 3262 community residents aged 5070. Depressive symptoms were defined as a Center for Epidemiological Studies of Depression Scale (CES-D) score of 16 or higher. Circulating 25(OH)D concentrations were measured by radioimmunoassay.
Results

The prevalence of depressive symptoms was lower in the top tertile of 25(OH)D concentrations compared to the lowest tertile (7.2% vs. 11.1%) in the study population (odds ratio, 0.62; 95% confidence interval, 0.460.83; P for trend = 0.002). This association was substantially attenuated after controlling for various confounding factors, and disappeared after including geographic location in the model. Stratified analysis by location did not find any association between depressive symptoms and 25(OH)D levels among participants from either Beijing or Shanghai.
Limitations

Due to the cross-sectional study design, causal relation remains unknown.
Conclusions

Depressive symptoms are not associated with 25(OH)D concentrations in middle-aged and elderly Chinese. Further prospective studies are required to determine whether they are correlated.

Keywords: Depression; 25-hydroxyvitamin D; Chinese; Cross-sectional study

Abbreviations: CES-D, Center for Epidemiological Studies of Depression Scale; 25(OH)D, 25-hydroxyvitamin D
Article Outline

1. Introduction
2. Subjects and methods

2.1. Participants
2.2. Assessment of depressive symptoms
2.3. Plasma 25(OH)D measurement
2.4. Covariates
2.5. Statistical analyses

3. Results
4. Discussion
Role of funding source
Conflict of Interest
Acknowledgements
References

1. Introduction
Major depression was the fourth leading cause of disease burden in 2000 and is projected to become the second by 2020 (Lopez and Murray, 1998). Vitamin D receptor and the vitamin D activating enzyme 1-alpha-hydroxylase are widely distributed in human brain, particularly hypothalamus, and it is speculated that 25-hydroxyvitamin D [25(OH)D] deficiency might increase the odds of suffering depression (Berk et al., 2007). Despite a growing interest in this area, few studies have evaluated the association between depression and blood 25(OH)D levels in the general population (Hoogendijk et al., 2008). We reported herein the results from the Nutrition and Health of Aging Population in China (NHAPC) project, a population-based cross-sectional study in middle-aged and elderly Chinese.

2. Subjects and methods
2.1. Participants

The study design of NHAPC project has been described in detail previously ([Pan et al., 2008a] and [Pan et al., 2008b]). In brief, this study was simultaneously conducted in Beijing (north) and Shanghai (south) among non-institutionalized individuals of 5070 year s old in 2005. One rural county and two urban districts were selected in both cities. Individuals were excluded if they had one of the following conditions: self-care disabilities; psychological severe disorders; diagnosed with cancer, CVD, Alzheimer's disease and dementia within the 6 month period before the start of the study; or currently diagnosed with tuberculosis, AIDS and other communicable diseases. In total, 3262 eligible participants with complete information of questionnaire, physical examination and 25(OH)D data were included in the analyses. The study was approved by the Institutional Review Board of the Institute for Nutritional Sciences, and informed consent was obtained from each participant.
2.2. Assessment of depressive symptoms

The self-reported 20-item Center for Epidemiologic Studies-Depression (CES-D) Scale (Radloff, 1977), validated in Chinese populations previously (Zhang and Norvilitis, 2002), was used to measure the presence of depressive symptoms experienced during the previous week. Binary categories of respondents were created using a generally accepted cutoff point of 16, which has a good validity for major depression (Radloff, 1977).
2.3. Plasma 25(OH)D measurement

Circulating 25(OH)D concentrations were measured by radioimmunoassay using acetonitrile extracts of the plasma (DiaSorin, Stillwater, MN).
2.4. Covariates

In-house, face-to-face interviews were conducted by trained research staff using a standardized questionnaire ([Pan et al., 2008a] and [Pan et al., 2008b]). Socio-demographic variables included age, gender, geographic location (Beijing/Shanghai), residential region (urban/rural), marital status (having spouse or not), annual household income, and social activity level (active/inactive). Current smoking status (yes/no) also was assessed. The physical activity level for each individual was classified as low, moderate or high according to the International Physical Activity Questionnaire scoring protocol with minor modification (Craig et al., 2003). Information of the presence of the following chronic diseases was obtained: diabetes, dyslipidemia, hypertension, heart disease, cerebravascular disease, chronic bronchitis, gastrointestinal ulcer, arthritis, rheumatic and rheumatoid arthritis, fracture, cataract, and glaucoma. Participants were categorized into three groups according to the number of reported chronic diseases (none, 12, and ≥ 3). Body height and weight of the participants were measured and body mass index was calculated as weight (kg)/height2 (m2).
2.5. Statistical analyses

Multivariate logistic regression was used with depressive symptoms as the outcome and plasma 25(OH)D concentrations (tertiles) as a predictor, along with adjustment for potential confounders (age, sex, urban/rural, body mass index, physical activity level, smoking status, social activity level, marital status, household income, and number of chronic diseases). Geographic location (Beijing/Shanghai) was further included in the model to determine its influence, and stratified analysis by location was also performed. The natural-logarithm transformation was performed to approximate normality CES-D scores or 25(OH)D concentrations when necessary. All statistic tests were based on 2-sided probability using Stata 9.2 (StataCorp, College Station, Texas).
3. Results

The prevalence of depressive symptoms was lower in the top tertile of 25(OH)D compared to the lowest tertile (78 vs. 121 cases of 1087 participants, or 7.2% vs. 11.1%) in the study population (odds ratio = 0.62, 95% confidence interval = 0.460.83, P = 0.001, P for trend = 0.002, Table 1). This association was substantially attenuated after controlling for aforementioned confounding factors, and disappeared after including geographic location in the model.
Table 1.

Risk of having depression according to tertiles of plasma 25-hydroxyvitamin D
25-hydroxyvitamin D categories (nmol/L)P for trend
Q1Q2Q3
Total, continuous level26.1 ± 5.941.1 ± 4.165.1 ± 16.0
Cases/participants (%)121/1087 (11.1)113/1088 (10.4)78/1087 (7.2)
Unadjusted association1.000.93 (0.711.21)0.62 (0.460.83)0.002
Model 1a1.000.96 (0.721.27)0.67 (0.490.92)0.016
Model 2b1.001.11 (0.811.51)0.75 (0.531.06)0.122
Model 3c1.001.38 (1.001.90)1.35 (0.941.96)0.075
Beijingd, continuous level23.4 ± 4.935.6 ± 3.0254.7 ± 13.6
Cases/participants (%)84/540 (15.6)79/541 (14.6)81/541 (15.0)
Unadjusted association1.000.93 (0.671.30)0.96 (0.691.33)0.789
Model 1a1.000.97 (0.691.36)1.09 (0.771.53)0.643
Model 2b1.001.25 (0.851.83)1.24 (0.841.84)0.271
Shanghaid, continuous level30.6 ± 7.247.7 ± 4.472.4 ± 16.4
Cases/participants (%)21/546 (3.9)27/547 (4.9)20/547 (3.7)
Unadjusted association1.001.30 (0.732.33)0.95 (0.511.77)0.875
Model 1a1.001.06 (0.571.96)0.72 (0.361.44)0.325
Model 2b1.001.20 (0.602.43)0.88 (0.411.88)0.668
Full-size table

Data are expressed as mean ± standard deviation or odds ratio (95% confidence interval) unless specified.
a Model 1: adjusted for age, sex, and urban/rural.
b Model 2: further adjusted for body mass index, physical activity, smoking status, number of chronic diseases, social activity level, marital status, household income.
c Model 3: further adjusted for geographic location.
d Geographic location specific tertiles were calculated.

View Within Article


Since the prevalence of depression had a dramatic geographic disparity (14.9% in Beijing and 4.1% in Shanghai) (Pan et al., 2008a), and 25(OH)D concentrations also substantially differed between the two cities (32% higher in Shanghai compared to Beijing), we speculated that geographic location might act as an effect modifier. However, after stratifying for geographic location we failed to find any association in participants either from Beijing or Shanghai (Table 1, Fig. 1). The results were materially the same when we categorized the 25(OH)D concentrations as binary variable (< 50 and &#8805; 50 nmol/L) in the logistical models, or used continuous values for CES-D score and 25(OH)D concentrations in the linear regression models (data not shown).

Full-size image (23K) - Opens new windowFull-size image (23K)

Fig. 1. Adjusted CES-D scores according to tertiles of plasma 25-hydroxyvitamin D. CES-D = Center for Epidemiological Studies of Depression Scale; 25(OH)D = 25-hydroxyvitamin D. Values are given as means (95% confidence intervals) adjusted for age, sex, and urban/rural, body mass index, physical activity, smoking status, number of chronic diseases, social activity level, marital status, household income.

View Within Article


4. Discussion

We did not find an association between depressive symptoms and 25(OH)D levels in the study population. The robust relation observed in the crude analysis was mainly due to the strong association of depressive symptoms and 25(OH)D with geographic location.

Vitamin D is a secosteroid structured hormone produced in the skin upon exposure to UVB-radiation or obtained from certain food products (for example, liver) (Holick, 2007). Active metabolites of vitamin D play an important role in calcium and phosphate homeostasis (Holick, 2007). In addition, a deficiency of vitamin D has been attributed to several chronic diseases, including osteoporosis, common cancers, autoimmune diseases, infectious diseases, and cardiovascular diseases (Holick, 2007). Recently, several small studies have investigated the possible link between depression and vitamin D status; however, findings have been inconsistent ([Armstrong et al., 2007], [Jorde et al., 2006], [Schneider et al., 2000] and [Wilkins et al., 2006]). These apparently conflicting results may be due to the fact that all these studies were of small sample size (n < 100), did not control for potential confounding factors, and were implemented in institutionalized populations [e.g., schizophrenia, depression and alcoholism (Schneider et al., 2000), secondary hyperparathyroidism (Jorde et al., 2006), Alzheimer disease (Wilkins et al., 2006), fibromyalgia (Armstrong et al., 2007)]. Until now, only one study was conducted in the general population and Hoogendijk et al. (2008) reported that depression severity (also measured by CES-D) was associated with decreased 25(OH)D levels in 1282 older Dutch adults aged 6595 years selected from different areas of the Netherlands. While they did not mention whether there was geographic disparity of depression, and geographic location was not included in the adjustment. Randomized clinical trials also yielded mixed results about vitamin D supplementation on symptoms of depression ([Dumville et al., 2006] and [Jorde et al., 2008]). Although there is ample biological evidence to suggest an important role for vitamin D in brain development and function (McCann and Ames, 2008), direct effects of vitamin D deficiency on depression in human are subtle.

A strong body of evidence has demonstrated the seasonality of mood (Eagles, 2003), and vitamin D levels also vary seasonally with low values during the winter period because of the reduced sun light (Holick, 2007). Therefore, there is a hypothesis that vitamin D may be the link between seasonality of mood and seasonal change in photoperiod (Berk et al., 2007). This has been supported by two small clinical pilot studies ([Gloth et al., 1999] and [Lansdowne and Provost, 1998]) with vitamin D supplementation improving the depression measures, but not in all studies (Dumville et al., 2006). However, in the present study we did not evaluate whether the depressive symptoms are seasonal as the survey was simultaneously conducted in both cities during April and June, thus reducing the seasonal influences. More studies are still needed to evaluate whether vitamin D is associated with seasonal affective disorders.

The main strength of our study is that we used data from a large population-based sample of both genders and from both northern and southern China, which is representative of populations of this age. Additionally, we controlled for various covariates known to be related to 25(OH)D levels and depressive symptoms in the analysis. Admittedly, we are aware of certain limitations in the present study. Firstly, the validity of the findings based on the self-reported measure of depression (CES-D), and we did not conduct the psychiatric diagnostic interview. However, the sensitivity of the CES-D to detect major depression is high (Radloff, 1977) and has been validated in Chinese populations (Zhang and Norvilitis, 2002), and diagnose of depression is not feasible to apply in large-scale epidemiological studies. Secondly, conclusions could not be made currently due to the cross-sectional nature of the present study.

In conclusion, we find no evidence that depressive symptoms are associated with 25(OH)D levels in the middle-aged and elderly Chinese in the present study. Further investigations (particularly prospective studies) are warranted to determine whether they are related.
Role of funding source

This study was funded by grants SIBS2008006 from the Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences to Dr. Xu Lin, KSCX1-YW-02 and KSCX1-YW-R-116 from the Knowledge Innovation Program of the Chinese Academy of Sciences, CH-2006-0941 from the Shanghai-Unilever Research Development Fund.

There were no conflicts of interest of the sponsors in study design, data collection, analysis and interpretation of data, and in the decision to submit the paper for publication.
Conflict of Interest

The authors have no conflicts of interest to declare.
Acknowledgements

The authors want to express their sincere appreciation to the study participants and to the researchers and the healthcare professionals from the Centers for Disease Control and Prevention in Beijing and in Shanghai. We also want to thank Dr. Tony Dadd for his statistical help.
References

Armstrong et al., 2007 D.J. Armstrong, G.K. Meenagh, I. Bickle, A.S. Lee, E.S. Curran and M.B. Finch, Vitamin D deficiency is associated with anxiety and depression in fibromyalgia, Clin. Rheumatol. 26 (2007), pp. 551554. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (8)

Berk et al., 2007 M. Berk, K.M. Sanders, J.A. Pasco, F.N. Jacka, L.J. Williams, A.L. Hayles and S. Dodd, Vitamin D deficiency may play a role in depression, Med. Hypotheses 69 (2007), pp. 13161319. Article | PDF (83 K) | View Record in Scopus | Cited By in Scopus (5)

Craig et al., 2003 C.L. Craig, A.L. Marshall, M. Sjostrom, A.E. Bauman, M.L. Booth, B.E. Ainsworth, M. Pratt, U. Ekelund, A. Yngve, J.F. Sallis and P. Oja, International physical activity questionnaire: 12-country reliability and validity, Med. Sci. Sports Exerc. 35 (2003), pp. 13811395. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (440)

Dumville et al., 2006 J.C. Dumville, J.N. Miles, J. Porthouse, S. Cockayne, L. Saxon and C. King, Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women, J. Nutr. Health Aging 10 (2006), pp. 151153. View Record in Scopus | Cited By in Scopus (10)

Eagles, 2003 J.M. Eagles, Seasonal affective disorders, Br. J. Psychiatry 182 (2003), pp. 174176. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (10)

Gloth et al., 1999 F.M. Gloth 3rd, W. Alam and B. Hollis, Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder, J. Nutr. Health Aging 3 (1999), pp. 57. View Record in Scopus | Cited By in Scopus (44)

Holick, 2007 M.F. Holick, Vitamin D deficiency, N. Engl. J. Med. 357 (2007), pp. 266281. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (275)

Hoogendijk et al., 2008 W.J. Hoogendijk, P. Lips, M.G. Dik, D.J. Deeg, A.T. Beekman and B.W. Penninx, Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults, Arch. Gen. Psychiatry 65 (2008), pp. 508512. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (5)

Jorde et al., 2006 R. Jorde, K. Waterloo, F. Saleh, E. Haug and J. Svartberg, Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso study, J. Neurol. 253 (2006), pp. 464470. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (14)

Jorde et al., 2008 R. Jorde, M. Sneve, Y. Figenschau, J. Svartberg and K. Waterloo, Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial, J. Intern. Med. 264 (2008), pp. 599609. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (2)

Lansdowne and Provost, 1998 A.T. Lansdowne and S.C. Provost, Vitamin D3 enhances mood in healthy subjects during winter, Psychopharmacology 135 (1998), pp. 319323. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (44)

Lopez and Murray, 1998 A.D. Lopez and C.C. Murray, The global burden of disease, 19902020, Nat. Med. 4 (1998), pp. 12411243. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (413)

McCann and Ames, 2008 J.C. McCann and B.N. Ames, Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?, FASEB J. 22 (2008), pp. 9821001. View Record in Scopus | Cited By in Scopus (4)

Pan et al., 2008a A. Pan, O.H. Franco, Y.F. Wang, Z.J. Yu, X.W. Ye and X. Lin, Prevalence and geographic disparity of depressive symptoms among middle-aged and elderly in China, J. Affect. Disord. 105 (2008), pp. 167175. Article | PDF (160 K) | View Record in Scopus | Cited By in Scopus (1)

Pan et al., 2008b A. Pan, X. Ye, O.H. Franco, H. Li, Z. Yu, S. Zou, Z. Zhang, S. Jiao and X. Lin, Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the Nutrition and Health of Aging Population in China Study, J. Affect. Disord. 109 (2008), pp. 7582. Article | PDF (162 K) | View Record in Scopus | Cited By in Scopus (2)

Radloff, 1977 L.S. Radloff, The CES-D Scale: a self-report depression scale for research in the general population, Appl. Psychol. Meas. 1 (1977), pp. 385401. Full Text via CrossRef

Schneider et al., 2000 B. Schneider, B. Weber, A. Frensch, J. Stein and J. Fritz, Vitamin D in schizophrenia, major depression and alcoholism, J. Neural Transm. 107 (2000), pp. 839842. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (13)

Wilkins et al., 2006 C.H. Wilkins, Y.I. Sheline, C.M. Roe, S.J. Birge and J.C. Morris, Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults, Am. J. Geriatr. Psychiatry 14 (2006), pp. 10321040. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (27)

Zhang and Norvilitis, 2002 J. Zhang and J.M. Norvilitis, Measuring Chinese psychological well-being with Western developed instruments, J. Pers. Assess. 79 (2002), pp. 492511. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (22)


Corresponding Author Contact InformationCorresponding author. Institute for Nutritional Sciences, Chinese Academy of Sciences, 294 Tai-Yuan Rd., Shanghai, 200031, China. Tel.: +86 21 54920249; fax: +86 21 54920291.


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:jrbecker76 thread:885916
URL: http://www.dr-bob.org/babble/20090313/msgs/885959.html